The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

getexcalibur.com

Founded Year

2013

Stage

Seed VC - III | Alive

Total Raised

$60K

About Excalibur

Excalibur utilizes the mobile phone to act as a secure hardware token for any and all authentication and authorization needs inside an enterprise. The company aims to move all forms of authentication and authorization away from passwords and replace them with smartphone-based multi-factor authentication.

Excalibur Headquarter Location

Hraničná 12

Poprad, 05801,

Slovakia (Slovak Republic)

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Excalibur

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Excalibur is included in 1 Expert Collection, including Cybersecurity.

C

Cybersecurity

4,896 items

Excalibur Patents

Excalibur has filed 452 patents.

The 3 most popular patent topics include:

  • Social networking services
  • Wireless networking
  • Computer network security
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/14/2020

4/5/2022

CubeSats, Manned spacecraft, Dragon (spacecraft), NASA programs, Proposed spacecraft

Grant

Application Date

5/14/2020

Grant Date

4/5/2022

Title

Related Topics

CubeSats, Manned spacecraft, Dragon (spacecraft), NASA programs, Proposed spacecraft

Status

Grant

Latest Excalibur News

Excalibur Launches New Covid-19 ‘Test to Go’ App for Work, Leisure and Travel

Jun 1, 2021

Excalibur Launches New Covid-19 ‘Test to Go’ App for Work, Leisure and Travel LONDON--(BUSINESS WIRE)--Test To Go, the world’s first mobile phone App that enables people to conduct rapid COVID-19 tests, record the results instantly and create a digital certificate showing their coronavirus status has been launched today. The ‘Test To Go’ app, developed by Excalibur Healthcare Services Ltd., and powered by MagnifEye, is now available for businesses and individuals and is designed for work, leisure or travel. The app is free to download on the App Store and Google Play . Further details are available on www.testtogoapp.com Users of this unique App are able to go safely to workplaces, large-scale events and can travel internationally with confidence, having verified their COVID-19 status. The App offers an ‘enterprise’ setting which is particularly suited for use by employers and managers in the office, travel, events, hospitality, entertainment, sport, leisure, health and social care sectors. There is also a separate setting for individuals. The ‘Test To Go’ App is used in conjunction with a lateral flow test. Users can purchase Excalibur’s Rapid Antigen Tests for use with the app. The App eliminates errors in reading rests and during extensive trials involving over 15,000 test samples, the App was up to three times more effective than the human eye in confirming low levels of infection. Recorded test results are submitted within seconds to Public Health England national database for monitoring infection levels. The Test To Go App can also record the user’s PCR test results straight from the laboratory should they be required for travel purposes and has the capacity to add vaccine and serology certification. The ‘Test To Go’ App has been developed through a pioneering UK partnership between Cambridge-based Excalibur and Sensyne Health plc, the Oxford-based clinical AI company. A combination of Excalibur’s advanced COVID-19 testing systems and Sensyne’s pioneering algorithm ‘MagnifEye’ technology has created this easy-to-use digital solution. The Department of Health & Social Care (DHSC) has signed a production contract to use the technology for reading COVID-19 lateral flow diagnostic tests as part of the UK government’s asymptomatic testing programme. The ‘Test To Go’ App quickly trains users to administer an Excalibur lateral flow test, then it simultaneously uploads and reads the test result and formulates a shareable digital certificate that validates the date of training of the user, the time of the test result itself and the resulting COVID-19 health status of the person. The App can read all types of lateral flow tests but is only available for such lateral flows subject to agreement with the manufacturers. Excalibur’s COVID-19 rapid test was developed in its own Cambridge laboratory and then rigorously tested by leading university research laboratories, pharmaceutical companies and international hospital groups. It has been comprehensively validated in over 12,000 symptomatic and asymptomatic samples and settings and exceeds the Department of Health and Social Care’s (DHSC) acceptable criteria. The test is also registered with the UK regulator MHRA, and is one of the fastest, most accurate and reliable tests on the market. Professor Sir Chris Evans, chairman and CEO of Excalibur Healthcare Services, said: “The ‘Test To Go’ App is one of a kind – and an excellent example of British partnership and innovation. It’s a very exciting development and can play an important part in helping businesses and their employees get back to normal. People can go to their offices or get on a train or a plane knowing exactly their COVID-19 status. We think this will also be an invaluable tool in the entertainment sector. “Every effort needs to be made to ensure that infection rates are kept under control. Taking a reliable test and creating a credible digital record of the result will be extremely useful in doing this and it is important that test results are submitted to the national database. As an independent company, we have committed to doing this and will are looking to collaborate with other test manufacturers to develop this further.” ENDS

Excalibur Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Excalibur Rank

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.